177 related articles for article (PubMed ID: 35723337)
1. Single Circulating-Tumor-Cell-Targeted Sequencing to Identify Somatic Variants in Liquid Biopsies in Non-Small-Cell Lung Cancer Patients.
Barbirou M; Miller A; Manjunath Y; Ramirez AB; Ericson NG; Staveley-O'Carroll KF; Mitchem JB; Warren WC; Chaudhuri AA; Huang Y; Li G; Tonellato PJ; Kaifi JT
Curr Issues Mol Biol; 2022 Feb; 44(2):750-763. PubMed ID: 35723337
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
[TBL] [Abstract][Full Text] [Related]
3. Correlation Between Circulating Tumor Cell DNA Genomic Alterations and Mesenchymal CTCs or CTC-Associated White Blood Cell Clusters in Hepatocellular Carcinoma.
Wang C; Luo Q; Huang W; Zhang C; Liao H; Chen K; Pan M
Front Oncol; 2021; 11():686365. PubMed ID: 34178679
[TBL] [Abstract][Full Text] [Related]
4. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
5. Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in
Pailler E; Faugeroux V; Oulhen M; Mezquita L; Laporte M; Honoré A; Lecluse Y; Queffelec P; NgoCamus M; Nicotra C; Remon J; Lacroix L; Planchard D; Friboulet L; Besse B; Farace F
Clin Cancer Res; 2019 Nov; 25(22):6671-6682. PubMed ID: 31439588
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor DNA from non-small cell lung cancer brain metastasis in cerebrospinal fluid samples.
Ma C; Yang X; Xing W; Yu H; Si T; Guo Z
Thorac Cancer; 2020 Mar; 11(3):588-593. PubMed ID: 31944608
[TBL] [Abstract][Full Text] [Related]
7.
Kapeleris J; Kulasinghe A; Warkiani ME; Oleary C; Vela I; Leo P; Sternes P; O'Byrne K; Punyadeera C
Transl Lung Cancer Res; 2020 Oct; 9(5):1795-1809. PubMed ID: 33209602
[TBL] [Abstract][Full Text] [Related]
8. The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer.
Cai J; Jiang H; Li S; Yan X; Wang M; Li N; Zhu C; Dong H; Wang D; Xu Y; Xie H; Wu S; Lou J; Zhao J; Li Q
Front Oncol; 2021; 11():751106. PubMed ID: 35273907
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy Detecting Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer: Preliminary Results of a Pilot Study.
Mastromarino MG; Parini S; Azzolina D; Habib S; De Marni ML; Luise C; Restelli S; Baietto G; Trisolini E; Massera F; Papalia E; Bora G; Carbone R; Casadio C; Boldorini R; Rena O
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672660
[TBL] [Abstract][Full Text] [Related]
10. Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer.
Davis AA; Zhang Q; Gerratana L; Shah AN; Zhan Y; Qiang W; Finkelman BS; Flaum L; Behdad A; Gradishar WJ; Platanias LC; Cristofanilli M
Breast Cancer Res; 2019 Dec; 21(1):137. PubMed ID: 31801599
[TBL] [Abstract][Full Text] [Related]
11. Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.
Marchetti A; Del Grammastro M; Felicioni L; Malatesta S; Filice G; Centi I; De Pas T; Santoro A; Chella A; Brandes AA; Venturino P; Cuccurullo F; Crinò L; Buttitta F
PLoS One; 2014; 9(8):e103883. PubMed ID: 25137181
[TBL] [Abstract][Full Text] [Related]
12. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing of glioblastoma circulating tumor cells: non-invasive solution for disease monitoring.
Kolostova K; Pospisilova E; Pavlickova V; Bartos R; Sames M; Pawlak I; Bobek V
Am J Transl Res; 2021; 13(5):4489-4499. PubMed ID: 34150029
[TBL] [Abstract][Full Text] [Related]
14. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
Fernandez SV; Bingham C; Fittipaldi P; Austin L; Palazzo J; Palmer G; Alpaugh K; Cristofanilli M
Breast Cancer Res; 2014 Oct; 16(5):445. PubMed ID: 25307991
[TBL] [Abstract][Full Text] [Related]
16. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
[TBL] [Abstract][Full Text] [Related]
17. The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients.
Cao L; Long L; Li M; Yang H; Deng P; Mao X; Xiang J; Li B; Zhang T; Hu C
Onco Targets Ther; 2018; 11():2637-2646. PubMed ID: 29780256
[TBL] [Abstract][Full Text] [Related]
18. Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice.
Cho BC; Loong HHF; Tsai CM; Teo MLP; Kim HR; Lim SM; Jain S; Olsen S; Park K
Curr Oncol; 2022 Mar; 29(3):2154-2164. PubMed ID: 35323374
[TBL] [Abstract][Full Text] [Related]
19. Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.
Pesta M; Shetti D; Kulda V; Knizkova T; Houfkova K; Bagheri MS; Svaton M; Polivka J
Diagnostics (Basel); 2022 Jul; 12(8):. PubMed ID: 35892510
[TBL] [Abstract][Full Text] [Related]
20. Analytical evaluation for somatic mutation detection in circulating tumor cells isolated using a lateral magnetophoretic microseparator.
Cho H; Kim J; Han SI; Han KH
Biomed Microdevices; 2016 Oct; 18(5):91. PubMed ID: 27628059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]